The court's holding and decision will be displayed here.

This section contains the nature of the case and procedural background.

King (P) received a test dose of a Zyderm treatment. Zyderm is manufactured by Collagen (D). The treatment consists of injecting cow tissues directly under the skin. Zyderm was approved and regulated by the FDA under the MDA. MDA imposes high standards in order to provide reasonable assurances of safety and effectiveness of medical procedures and products. A provision in MDA protects manufacturers of medical devices from state law intrusion. Shortly after receiving the test dose, P suffered muscle and joint pains, as well as other symptoms. P was diagnosed as suffering from an autoimmune disease because of the Zyderm treatment. P filed a strict liability, breach of warranty, and negligence action against D. The trial court granted a summary judgment to D because the actions were preempted by MDA. P appealed.

The legal issues presented in this case will be displayed here.

Legal analysis from Dean's Law Dictionary will be displayed here.